• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,243.34 -116.67
( -0.16%)
Global Indices
Nasdaq
51,098.17 -484.76
(-0.94%)
Dow Jones
7,440.28 -165.03
(-2.17%)
Hang Seng
66,711.59 -759.10
(-1.13%)
Nikkei 225
10,374.30 13.98
(0.13%)
Forex
USD-INR
95.73 0.01
(0.01%)
EUR-INR
111.21 0.07
(0.06%)
GBP-INR
128.58 -0.06
(-0.05%)
JPY-INR
0.60 0.00
(0.01%)

EQUITY - MARKET SCREENER

Valiant Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543998
INE0JWS01017
58.8745685
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VALIANTLAB
72.38
400.99
EPS(TTM)
Face Value()
Div & Yield %
1.02
10
0
 

Sikko Industries reports consolidated net loss of Rs 2.01 crore in the March 2026 quarter
May 25,2026
Net Loss of Sikko Industries reported to Rs 2.01 crore in the quarter ended March 2026 as against net loss of Rs 0.88 crore during the previous quarter ended March 2025. Sales declined 41.70% to Rs 10.99 crore in the quarter ended March 2026 as against Rs 18.85 crore during the previous quarter ended March 2025.

For the full year,net profit rose 19.44% to Rs 5.10 crore in the year ended March 2026 as against Rs 4.27 crore during the previous year ended March 2025. Sales rose 5.28% to Rs 65.01 crore in the year ended March 2026 as against Rs 61.75 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales10.9918.85 -42 65.0161.75 5
OPM %-31.39-6.58 -9.7710.28 -
PBDT-3.05-0.73 -318 6.936.72 3
PBT-3.26-0.91 -258 6.306.04 4
NP-2.01-0.88 -128 5.104.27 19